Joincare Pharmaceutical Group Industry Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and healthcare products primarily in China. The company offers chemical drug preparation products, including respiration, gastroenterology, anti-infection, gonadotropic, and psychiatric products; and traditional chinese drug preparation production, which includes anti-tumor and cold products. It also provides chemical APIs and intermediates; diagnostic reagents and equipment, including autoimmunity multiple detection platform and diagnostic kit for IgM; and healthcare products, which includes American ginseng tea and Jingxin menocare essence. In addition, the company engages in the wholesale and retail of skin care products, cosmetics, and other necessities. It offers its products in various forms, such as hormone tablets, oral liquids, and tablets. The company was founded in 1992 and is headquartered in Shenzhen, China.
Joincare Pharmaceutical Industry Dividend Announcement
• Joincare Pharmaceutical Industry announced a annually dividend of ¥0.18 per ordinary share which will be made payable on 2024-07-18. Ex dividend date: 2024-07-18
• Joincare Pharmaceutical Industry annual dividend for 2024 was ¥0.18
• Joincare Pharmaceutical Industry annual dividend for 2023 was ¥0.18
• Joincare Pharmaceutical Industry's trailing twelve-month (TTM) dividend yield is 1.56%
• Joincare Pharmaceutical Industry's payout ratio for the trailing twelve months (TTM) is 52.82%
• Joincare Pharmaceutical Industry's dividend growth over the last five years (2018-2023) was 2.02% year
• Joincare Pharmaceutical Industry's dividend growth over the last ten years (2013-2023) was 17.40% year
Joincare Pharmaceutical Industry Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-18 | ¥0.18 | annually | 2024-07-18 |
2023-07-21 | ¥0.18 | annually | 2023-07-21 |
2022-06-30 | ¥0.15 | annually | 2022-06-30 |
2021-06-25 | ¥0.15 | annually | 2021-06-25 |
2020-07-03 | ¥0.16 | annually | 2020-07-03 |
2019-05-24 | ¥0.16 | annually | 2019-05-24 |
2018-07-04 | ¥0.16 | annually | 2018-07-04 |
2017-08-04 | ¥0.14 | annually | 2017-08-04 |
2016-07-06 | ¥0.09 | annually | |
2015-08-10 | ¥0.09 | annually | |
2014-07-10 | ¥0.04 | annually | |
2013-07-25 | ¥0.04 | annually |
Joincare Pharmaceutical Industry Dividend per year
Joincare Pharmaceutical Industry Dividend growth
Joincare Pharmaceutical Industry Dividend Yield
Joincare Pharmaceutical Industry current trailing twelve-month (TTM) dividend yield is 1.56%. Interested in purchasing Joincare Pharmaceutical Industry stock? Use our calculator to estimate your expected dividend yield:
Joincare Pharmaceutical Industry Financial Ratios
Joincare Pharmaceutical Industry Dividend FAQ
Other factors to consider when evaluating Joincare Pharmaceutical Industry as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Joincare Pharmaceutical Industry stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Joincare Pharmaceutical Industry's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Joincare Pharmaceutical Industry publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Joincare Pharmaceutical Industry distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Joincare Pharmaceutical Industry are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Joincare Pharmaceutical Industry sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Joincare Pharmaceutical Industry distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Joincare Pharmaceutical Industry declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Joincare Pharmaceutical Industry's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Joincare Pharmaceutical Industry's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.